Evidence map›Paper›PMID 19079679›Full record

ArticleInternational journal of clinical and experimental medicine2008

Peripheral biomarkers in Autism: secreted amyloid precursor protein-alpha as a probable key player in early diagnosis.

Antoinette R Bailey, Brian N Giunta, Demian Obregon, William V Nikolic, Jun Tian, Cyndy D Sanberg, Danielle T Sutton, Jun Tan

Abstract read
In one paragraph

Article in International journal of clinical and experimental medicine, 2008. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 47 papers, 2 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
47citing papers in PubMed, 2 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

47 citing papers in PubMed, 2 syntheses or guidelines pooled it.

  1. Pooled it
  2. Pooled it
  3. Altered concentrations of amyloid precursor protein metabolites in the cerebrospinal fluid of patients with bipolar disorder.Neuropsychopharmacology : official publication of the American College of Neuropsychopharmacology · 2013
    Trial
  4. Article
  5. Article
  6. Article
  7. Review
  8. Review
  9. Article
  10. Article
  11. Article
  12. Article
  13. Article
  14. New Therapeutic Options for Fragile X Syndrome.Current treatment options in neurology · 2019
    Review
  15. Article
  16. Review
  17. Cerebrospinal fluid and the early brain development of autism.Journal of neurodevelopmental disorders · 2018
    Review
  18. Article
  19. Article
  20. Amyloid precursor protein in pancreatic islets.The Journal of endocrinology · 2017
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors.

Antoinette R Bailey
Brian N Giunta
Demian Obregon
William V Nikolic
Jun Tian
Cyndy D Sanberg
Danielle T Sutton
Jun Tan

Funding

Implication of HUCBC: a novel therapeutic strategy for Alzheimer's diseaseR01AG032432 · NIA · UNIVERSITY OF SOUTH FLORIDA · PI TAN, JUN · 2009 to 2013
$1.4M
The impact of HAART on HIV-1 Tat induced brain agingR01MH098737 · NIMH · UNIVERSITY OF SOUTH FLORIDA · PI GIUNTA, BRIAN · 2012 to 2015
$1.3M
NIA NIH HHS R01 AG032432NIMH NIH HHS R01 MH098737
6 · The paper itself

Abstract

Autism is a pervasive developmental disorder characterized by impairments in socialization and communication. There is currently no single molecular marker or laboratory tool capable of diagnosing autism at an early age. The purpose of this study is to explore the plausible use of peripheral biomarkers in the early diagnosis of autism via a sensitive ELISA. Here, we measured plasma secreted amyloid precursor protein alpha (sAPP-alpha) levels in autistic and aged-matched control blood samples and found a significantly increased level of sAPP-alpha in 60% of the known autistic children. We then tested 150 human umbilical cord blood (HUCB) samples and found significantly elevated levels of plasma sAPP-alpha in 10 of 150 samples. As an additional confirmatory measure, we performed Western blot analysis on these samples which consistently showed increased sAPP-alpha levels in autistic children and 10 of 150 HUCB samples; suggesting a group of autistic patients which could be identified in early childhood by levels of sAPP-alpha. While there is need for further studies of this concept, the measurement of sAPP-alpha levels in serum and human umbilical cord blood by ELISA is a potential tool for early diagnosis of autism.

Indexed as

Autismautism spectrum disorders (ASD)brain derived neurotrophic factor (BNDF)secreted amyloid precursor protein-α (sAPP-α)

Identifiers

PMID19079679
PMCPMC2596331

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.